LACOG GU Review

Congratulations on this successful event, with enriching multidisciplinary discussions!!

KARINE MARTINS TRINDADE Andrey Soares FLoscoMD

🇦🇷 🇧🇷 Brotherhood!

Very happy to have you here to make this meeting bigger!

Terrific session about access and how to improve care #gureview23 LACOG - Latin American Cooperative Oncology Group
Touching the point. Payers, providers, pharma, government, advocacy and medical societies are important players to improve care and decrease disparities. Research has an important role Diogo Rodrigues

After an outstanding Asociación Argentina de Oncología Clínica (AAOC) annual meeting we are here for the last day of one of the biggest and important GU meeting organized by LACOG - Latin American Cooperative Oncology Group GU team #gureview23 with my friend FLoscoMD and my boss Diogo Rodrigues

We are delighted with you on board on the team!

Very kind Dra. María Natalia Gandur Quiroga. Interesting challenge do my talks in spanish during Asociación Argentina de Oncología Clínica (AAOC)

Outstanding meeting of Asociación Argentina de Oncología Clínica (AAOC). Very interesting GU agenda

Comprehensive overview about 1st line therapy in mUC. And now we have a new criteria for decision therapy: Sade criteria for EV

Amazing dinner time during the Annual Argentine Association Meeting

#CongresoAAOC23
15 HS. Modulo Próstata.
Juan Pablo Sade Gustavo Villoldo José Máximo Barros, MD 🇦🇷 Diego Barreiro Carolina Passarella Urooncologia.arg UroTarget @UroTeragLA Daniel Castellano Andrey Soares Pablo CASTRO PEÑA Gonzalo Taetti Ramon Coronil Mauricio Fernandez L Martín Angel FLoscoMD Asociación Argentina de Oncología Clínica (AAOC)

Honored to join this important meeting. Anxious to have great discussions with Neeraj Agarwal, MD, FASCO Daniel Castellano Mauricio Fernandez L Juan Pablo Sade FLoscoMD Martín Angel #carolinapasarella

Interesting pool

Outstanding discussion about new data in metastatic urothelial carcinoma with Shilpa Gupta #ESMO23

Andrey Soares You are right. I always thought that the QoL data was difficult to interpret with usually several questions that are not relevant at all. But at the same, it is what we have for today. #ESMO23

Awesome plenary and together with you stayed even more exciting. Impactful and amazing data for UC patients. Longterm toxicity, sequencing and costs are major concerns #ESMO23

Adding that we need to talk with patients, families and caregivers if we are still looking for the most important symptons #ESMO23

Hard to disagree with you Andrey Soares #ESMO23

Increasingly #QOL do not seem to align with objective toxicity data and we should be asking why that is…

Outstanding talk #ESMO23

It highlight the importance of explain the outcomes and if the treatment is curative or not! Because if the therapy do not cure patients, QoL is very important! #ESMO23